New patent expiration for Takeda Pharms drug ULORIC

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ULORIC
Annual Drug Patent Expirations for ULORIC

Uloric is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.

ULORIC drug price trends.

Drug patent litigation for ULORIC.

This drug has twenty-five patent family members in fifteen countries.

The generic ingredient in ULORIC is febuxostat. One supplier is listed for this compound. Additional details are available on the febuxostat profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top